China Telemedicine Market Analysis Sample Report

China Telemedicine Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)

This report presents a strategic analysis of China Telemedicine Market
and a forecast for its development in the medium and long term. It provides
a comprehensive overview of the market value, dynamics, segmentation,
characteristics, main players, trends and insights, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the China Telemedicine Market, and offers
unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Future Opportunities
• Conclusion

4 A Sample Report on Report Title I Confidential
Table of Contents
1. China Telemedicine Market Overview…………………………………………..……………………………………....….................................07
1.1 Introduction
1.3 Market size and forecast
2. Market Growth Drivers and Restraints …………………………………………………………………….…………………….…….………….10
2.1 Market Growth Drivers
2.1.1 5G Technology
2.1.2 Scarcity and uneven resources of medical resources
2.1.3 China’s aging society
2.1.4 Agile and cheaper Installations
2.2 Market Restraints
2.2.1 High cost of remote consultation
2.2.2 Payment and technical dilemma
2.2.3 China’s Policies in Telemedicine
2.2.4 Strict guidelines against personal information protection

Table of Contents (continued)
3. Major Telemedicine Practices…..…………………………………………………………………………………..……………….……………....18
3.1 Store and Forward
3.2 Remote patient monitoring
3.3 Real time telemedicine
4. Telemedicine Market Segmentation………………………..……………………………………………………………...……..……….…….….20
4.1 By Products and Services
4.2 By Type
4.3 By Specialty
4.4 By Delivery Mode
5. Telemedicine Major Products Market Share…………………………………………………………...…………..…..............................….…27
5.1 Market Analysis, Insights and Forecast - By Revenue
6. Competitive Landscape……………………………………………………………………………………………………………………………....29
6.1 Major Players Revenue

Table of Contents (continued)
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials) ….……………………………….…...…...32
7.1 Ali Health
7.2 JD Health
7.3 We Doctor
7.4 Ping An Good Doctor
8. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………….…………..41
8.1 Regulatory Framework of China Telemedicine Market
9. Factors Driving Future Growth…………………………………………………………………………………………………………...…….…...44
9.1 Future Opportunities
9.2 Government Initiatives
10. Conclusion………………………………………………………………………………………………………………………………….…………47

China Telemedicine Market Analysis
1. Overview

1.1 Introduction
▪ The development of telemedicine in China began in the 1980s. In 1986, the Guangzhou Ocean Shipping Company conducted
a cross-sea consultation for the emergency patients on the ocean-going freighter through telegraph, which was considered to
be the earliest telemedicine activity in China
▪ China is country with huge population and have flourished healthcare infrastructure, with rapid growth in communication. The
development of telemedicine in China is relatively new
▪ China’s healthcare industry has been forced to do a hard reset in 2020. Just as the 2003 SARS epidemic caused China
exposed the gaps in the country’s disease surveillance infrastructure, COVID-19 has exposed the cracks its delivery of
healthcare services
▪ There have been positive signs for the telemedicine and overall telehealth industry after the Covid-19 pandemic. There are
numerous initiatives planned by the government and also consumers are more likely to accept telemedicine practices now
▪ China shows a lot of potential for telemedicine providers as the country is still adapting to such services and a significant
portion of the largest population in the world is aging

1.2 Market Size & Forecast
▪ China Telemedicine market size stood at around $4.88 Bn in
2022 and is projected to reach $20.59 Bn by 2030, exhibiting a
CAGR of around 19.7% during the forecast period
▪ China along with few APAC countries contributing significantly
to the market is this region
▪ The growth of the market is attributed to rising support from the
government, and presence of a larger patient population
Key Analysis

2. Growth Drivers and Growth Restraints

2.1 Market Growth Drivers
Implementation of pregnancy
controlling activities
5G technology
Scarcity of medical resources
China’s aging society
Agile installations
High cost of remote
consultation
Payment & technical dilemma
China’s policies in telemedicine
Strict guidelines
Drivers
Restraints

Market Growth Drivers
2.1.1 5G technology
• Construction of 5G base stations is accelerating in
China and 5G networks are expected to cover
prefecture-level cities nationwide by the end of the
year
• 5G telemedicine trolley has been launched in
Wuhan Huoshenshan Hospital. In some places,
China Mobile has launched the application of “5G
infrared thermal imaging temperature
measurement” to realize the simultaneous scanning
and temperature measurement of many people

Market Growth Drivers (continued)
• In China, the distribution of superior medical resources is
extremely uneven.
2.1.2 Scarcity of medical resources
• More than 70% of the third-level grade-A hospitals are
located in the eastern region, making the potential demand
for telemedicine in the central and western regions huge
Sample

2.1.3 China’s aging society
• China’s population is aging, and immense
pressure is put on the younger generations to
care for the elderly who require means of
telemedicine
• According to data released by Statista the
proportion of the population over 65 years old
has reached 14.2% in 2021
Sample

2.1.4 Agile installations
Sample
• Cost of installing central stations and servers for
telemedicine is far cheaper than building a hospital
Sample
Sample

2.2.1 High cost of remote consultation
▪ Telemedicine has not yet been included in
medical insurance, which has technical and cost
challenges
▪ The technical dilemma is mainly due to the large
differences in the medical insurance system
from place to place, with different coverage,
reimbursement ratios, and technical interfaces,
which makes medical insurance payments
difficult
▪ First of all, remote consultation kind of services
are very expensive, comparable to the VIP
outpatient cost of a public tertiary hospital in a
big city, and the more remote it is, the more
difficult it is for patients to accept it
2.2.2 Payment & technical dilemma
Sample

2.2.3 China’s policies in telemedicine
▪ Legal restrictions for foreign medical institutions
competing in China are yet to be defined
▪ Chinese government’s take on such services
has not been supportive in the past
2.2.4 Strict Guidelines
▪ Digital platform providers in healthcare are highly
regulated and China has a lot of guidelines to
protect personal information which impacts the
current operations of telemedicine
Sample Sample

3. Telemedicine Practices

3. Telemedicine Practices
▪ Remote patient monitoring is one
specific form of telehealth that
involves using a device to collect
and transmit vital signs or
physiologic data from a patient
outside of the office
▪ That data is monitored by clinical
staff and used for ongoing patient
care, communication, and education
▪ Store-and-forward telemedicine
surpasses the need for the medical
practitioner to meet in person with
a patient
▪ Instead, patient information such
as medical images or biosignals
can be sent to the specialist as
needed when it has been acquired
from the patient
▪ Real-time telemedicine (also called
live telemedicine) makes it easy to do
a doctor-patient visit anytime,
anywhere
▪ Live telemedicine includes any two-
way communications (including video
conferencing and phone
consultations) that let providers and
patients communicate in real-time
4.2 4.3
3.1 Store and forward 3.2 Remote patient monitoring 3.3 Real time telemedicine

4. Market Segmentation

Snapshot of Telemedicine Market Segmentation
Market
Restraints
By Products and Services
By Type
By Specialty
By Delivery Mode
Telemedicine
Market
Segmentation

Snapshot of Telemedicine Market Segmentation
Products and Services Type Specialty Delivery Mode
• Software and Hardware
• Tele-Consulting
• TeleEducation/Training
• Tele-hospital
• Tele-home
• Cardiology
• Gynecology
• Neurology
• Orthopedics
• Telemedicine
• Mental health
• Others
• Mobile
• Call Centers
• Web

▪ The telemedicine market for the software and hardware
segment was worth US$ xx Bn in 2022 and is projected to
reach US$ xx Bn by 2030; it is expected to grow at a
CAGR of xx% during the forecast period
▪ The market for the tele-consulting segment is estimated to
be worth US$ xx Bn by 2030 and is expected to grow at a
CAGR of 20.3% during the forecast period
4.1 Market Segmentation: By Products and Services
China Telemedicine Market Share by Products and Services 2022 Key Insights
Software and
Hardware
Tele-Consulting Tele Education/
Training

▪ In 2022, the tele-hospital segment held the largest share of
the market, by type. However, the demand for telehome is
also expected to grow at the fastest rate during the coming
years
▪ The telemedicine market for the tele-hospital segment was
worth US$ xx Bn in 2022 and is projected to reach US$ xx Bn
by 2030; it is expected to grow at a CAGR of xx% during the
forecast period
▪ The market for the tele-home segment is estimated to be
worth US$ xx Bn by 2030 and is expected to grow at a CAGR
of 20.1% during the forecast period
4.2 Market Segmentation: By Type
China Telemedicine Market Share by Type 2022 Key Insights
Telehospital Tele-home

4.3 Market Segmentation: By Specialty
Key Assumptions
Cardiology
Gynecology
Neurology
Orthopedics
Dermatology
Mental Health
Others
Cardiology Gynecology Neurology Orthopedics
Dermatology Mental Health Others
▪ In China Telemedicine market, the topical segment held
a large share of the market owing to the rise in the
demand for topical Telemedicine drugs such as anti-
inflammatory agents, anti-infective, local anesthetics,
cleansers, and emollients to treat acne.
China Telemedicine Market Share by Specialty 2022

4.4 Market Segmentation: By Delivery Mode
China Telemedicine Market Share by Delivery Mode 2022
▪ China telemedicine market, based on the delivery mode
was segmented into mobile, web, and call centers.
▪ In 2022, the mobile segment held the largest share of the
market, by delivery mode.
Key Insights
Mobile Call Centres Web

5. Telemedicine Service Market Share

Top Brands in Telemedicine Market
5.1 Major Telemedicine Products Market Share
Key Insights
China Telemedicine Major Products Market Share
Brand 1 Brand 2 Brand3 Brand 4

6. Competitive Landscape

6.1 Major Players Revenue (Current and Forecast)
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Ali Health $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
JD Health
$xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
We Doctor $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Ping An Good Doctor $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Revenue of Telemedicine Market Players ($Bn)

Key Players by Revenue Growth and Market Share
Ali Health
JD Health
WeDoctor
Ping An Good Doctor
Telemedicine Key Players ($Bn)
Revenue Market Share Growth

7. Key Company Profiles

7.1 Ali Health
Company Name: Ali Health
Year of Establishment: 2014
Beijing, Beijing, China
Revenue: US$xx Bn
Website https://www.alihealth.cn/
Sample
Company Profile

Ali Health (continued)
Key Developments
▪ Ali Health and Bo'ao Winhealth Rare Disease Medical Center Jointly Launched the "Global Drug Information Platform for Rare
Diseases"
▪ Backed by a subsidiary of Alibaba Health Information Technology Ltd, LinkDoc Technology Ltd, a medical data company, filed for an
initial public offering in the United States
Breakdown of net revenue by segment, 2022
Revenues ($Mn), 2021-2030
1 2 3 4
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$xx
xx

Sample
Headquarter: Beijing, China
Revenue: $xx Bn
Website: https://ir.jdhealth.com/sc/index.php
7.2 JD Health
Company Name: JD Health
Company Profile

JD Health (continued)
Key Developments
▪ Shanghai-based Ping An Good Doctor will push its Family Doctor strategy, with AI diagnosis and online health-care services in China,
which may ease hospital and social pressure in an aging society
▪ Ping An Good Doctor Unveils Strategic 2.0 Continuum : Strives to provide customers with "easier, faster and more affordable" user
experience through service channel upgrade, ecosystem optimization and Family Doctor Memberships
1 2 3 4
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$xx
xx

Sample
Company Name: We Doctor
Headquarter: Hangzhou, China
Revenue: US$xx Bn
Website: ://www.guahao.com
7.3 We Doctor
Company Profile

We Doctor (continued)
Key Developments
▪ We Doctor’s planned float —which could have raised as much as $3 billion — got caught up in China’s tightening oversight of how its
tech giants manage the data they collect
▪ Tencent-backed WeDoctor, one of the first and biggest unicorns in digital health care, has filed for an IPO in April 2021
1 2 3 4
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$xx
xx

7.4 Ping An Good Doctor
Company Name: Ping An Good Doctor
Headquarter: Guangdong, China
Revenue: $xxBn
Website: https://www.jk.cn/
Sample
Company Profile

Ping An Good Doctor (continued)
Key Developments
▪ JD Health and Sanofi China will expand their existing collaboration to building general and digitalized health management solutions
for patients with chronic diseases in China – Jun2021
▪ JD Health, the health-care unit of Chinese e-commerce giant JD.com, has raised $3.5 billion in a Hong Kong initial public offering
1 2 3 4
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$xx
xx

8. Healthcare Policy and Regulatory Landscape

8.1 Regulatory Framework of China Telemedicine Market
The development of telemedicine in China
began in the 1980s. In 2017, 22 provinces
in China established telemedicine platforms
covering 13,000 medical institutions,
providing teleconsultation, telediagnosis,
and remote medical education
The Three Measures are a positive sign that
Chinese officials are attempting to employ
Internet technology to optimize medical
resource allocation and delivery, ease
medical resource distribution at the grass-
roots level, and integrate and exchange
regional medical resources
In 1997, the Jinwei Medical Network in
China was officially opened to provide
remote, off-site, real-time, and dynamic live
television consultations for patients with
severe illness. The Chinese hospitals are
divided into 3 levels: tertiary hospitals,
secondary hospitals, and primary hospitals
The tertiary hospitals are the main providers
of telemedicine services. (Telemedicine
Information Professional Committee of
China) TIPC is a professional organization
in the telemedicine industry, gathering
telemedicine practitioners and hospital
administrators from different provinces in
China

Regulatory Framework of India Dermatology Therapeutic Market
For years, Internet-based medical services in China have existed in a legal “grey” area caused by
uncertainties to do with the Chinese regulator’s policies. On September 14, 2018, the Chinese
National Health Commission ("NHC") and the National Administration of Traditional Chinese
Medicine released three trial measures with a scope of application wide enough to cover almost all
key aspects of Internet-based medical services, all of which become effective on 17 July 2018:
• The Telemedicine Services Administrative Specifications ("Telemedicine Specifications")
• The Internet Diagnosis Administrative Measures ("Internet Diagnosis Measures")
• The Internet Hospital Administrative Measures ("Internet Hospital Measures")
The Three Measures go some way towards addressing complaints from stakeholders in the
healthcare sector that the Internet healthcare market has not been heading in a positive direction due
to the lack of a clear policy roadmap.

9. Factors Driving Future Growth

9.1 Future Opportunities
.
With the deepening of “Internet Plus”,
Internet economy has become an
important factor in China’s economic
development. “Internet + medical
treatment” has been constantly
applied and developed.
With the use of automated and intelligent
technologies, telemedicine is gaining
more and more recognition from patients.
Therefore, it can drive the increase of
huge demands and the potential space
of telemedicine market will be huge
Acceleration of digital initiatives as
94% of healthcare professional in
China use any digital health
technology or mobile health apps
which is very high compared to
average of 15 other countries
Future
Opportunities

9.2 Government initiatives
At the national conference on the
medical reform held in July 2021,
an emphasis should be placed on
speeding up the construction of
regional medical centers and
county medical communities,
promoting traditional Chinese
medicine, building teams of
doctors for rural areas and
supporting and encouraging the
development of the “Internet +
Healthcare” industry
In April 2021 China announced its
decision to greenlight the online
sales of prescription drugs. It
will give patients more options
and make it easier for the public
to access healthcare services,
experts said
China has built the world's largest
5G high-speed mobile network
with 260 Bn 5G mobile
connections. The Chinese
government’s recent extensive 5G
rollout will now cover even remote
regions and is likely to further
improve the adoption of telehealth
services

10. Conclusion

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and insightful
research
Reliable
The data is prepared by a
team of highly qualified &
experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to confidently
make smarter business and
strategic decisions
Real
Covers everything you
would need to know about
the market including
market size, competitive
analysis & much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.

China Telemedicine Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to China Telemedicine Market Analysis Sample Report

Similar to China Telemedicine Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

China Telemedicine Market Analysis Sample Report